Total Payments
$2,071
2024 Payments
$568.46
Companies
20
Transactions
80
Medicare Patients
2,672
Medicare Billing
$134,519
Payment Breakdown by Category
Food & Beverage$2,059 (99.4%)
Education$11.71 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,059 | 79 | 99.4% |
| Education | $11.71 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $745.60 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $571.04 | 9 | $0 (2024) |
| Lilly USA, LLC | $217.36 | 7 | $0 (2024) |
| Novo Nordisk Inc | $71.55 | 5 | $0 (2023) |
| Amgen Inc. | $67.71 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45.73 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $44.31 | 3 | $0 (2024) |
| Amarin Pharma Inc. | $43.49 | 3 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $40.46 | 3 | $0 (2024) |
| Ethicon US, LLC | $32.73 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $568.46 | 21 | Lilly USA, LLC ($178.32) |
| 2023 | $483.37 | 16 | ABBVIE INC. ($271.51) |
| 2022 | $464.72 | 11 | ABBVIE INC. ($283.55) |
| 2021 | $554.28 | 32 | AstraZeneca Pharmaceuticals LP ($160.61) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: DIABETES CARE | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Cardiology | ||||||
| 10/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: PAIN | ||||||
| 08/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Bone Health | ||||||
| 08/02/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Bone Health | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Gastroenterology | ||||||
| 06/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Biological | ||||||
| 06/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Immunology | ||||||
| 05/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Bone Health | ||||||
| 05/07/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Obesity | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Respiratory | ||||||
| 04/12/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: ETONOGESTREL | ||||||
| 04/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $117.17 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $128.21 | General |
| Category: Diabetes | ||||||
| 12/19/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 729 | 1,076 | $202,269 | $40,963 |
| 2022 | 11 | 763 | 1,083 | $123,982 | $36,903 |
| 2021 | 10 | 706 | 992 | $119,290 | $37,096 |
| 2020 | 9 | 474 | 565 | $66,469 | $19,556 |
Total Patients
2,672
Total Services
3,716
Medicare Billing
$134,519
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 283 | $102,729 | $19,043 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 249 | $63,744 | $11,291 | 17.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 71 | 71 | $26,412 | $7,237 | 27.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 196 | 324 | $2,268 | $2,212 | 97.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 25 | 26 | $1,881 | $372.96 | 19.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 42 | 44 | $1,760 | $335.55 | 19.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 23 | $943.00 | $200.69 | 21.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 12 | $2,268 | $174.75 | 7.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 36 | 44 | $264.00 | $96.80 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 264 | 452 | $71,416 | $19,825 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 115 | $26,680 | $7,543 | 28.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 65 | 65 | $16,120 | $6,805 | 42.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 168 | 263 | $1,841 | $777.90 | 42.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 39 | 46 | $2,988 | $744.19 | 24.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 39 | 39 | $1,872 | $314.35 | 16.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $385.00 | $302.86 | 78.7% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 14 | 16 | $1,008 | $208.41 | 20.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 11 | 11 | $847.00 | $163.00 | 19.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 43 | 50 | $300.00 | $110.97 | 37.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 15 | $525.00 | $109.11 | 20.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 214 | 340 | $53,720 | $16,967 | 31.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 149 | 198 | $45,936 | $12,356 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $10,912 | $4,685 | 42.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 17 | 17 | $2,040 | $1,109 | 54.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 154 | 209 | $1,463 | $627.00 | 42.9% |
About Jared Scherer, PA-C
Jared Scherer, PA-C is a Physician Assistant healthcare provider based in Council Bluffs, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2020. The National Provider Identifier (NPI) number assigned to this provider is 1235761107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jared Scherer, PA-C has received a total of $2,071 in payments from pharmaceutical and medical device companies, with $568.46 received in 2024. These payments were reported across 80 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,059).
As a Medicare-enrolled provider, Scherer has provided services to 2,672 Medicare beneficiaries, totaling 3,716 services with total Medicare billing of $134,519. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Council Bluffs, IA
- Active Since 02/10/2020
- Last Updated 02/10/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1235761107
Products in Payments
- VRAYLAR (Drug) $464.09
- BREZTRI (Drug) $301.80
- MOUNJARO (Drug) $177.18
- QULIPTA (Drug) $144.89
- FARXIGA (Drug) $136.60
- AIRSUPRA (Drug) $132.64
- UBRELVY (Drug) $90.10
- EVENITY (Biological) $53.75
- Kerendia (Drug) $44.31
- Vascepa (Drug) $43.49
- XIFAXAN (Drug) $40.46
- VICRYL (Device) $32.73
- RYBELSUS (Drug) $30.33
- TREMFYA (Drug) $29.10
- OPSUMIT (Drug) $24.87
- Livalo (Drug) $24.22
- HUMIRA (Biological) $19.55
- STIOLTO RESPIMAT (Drug) $19.35
- NEXPLANON (Drug) $18.74
- REXULTI (Drug) $18.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Council Bluffs
Joyce Vacek, Pac, PAC
Physician Assistant — Payments: $6,942
Physician Assistant $6,942
Sara Rygol, Pa-C, PA-C
Physician Assistant — Payments: $6,705
Physician Assistant $6,705
Holly Baumann, Pa-C, PA-C
Physician Assistant — Payments: $4,026
Physician Assistant $4,026
Isabella Phillips, Pa, PA
Physician Assistant — Payments: $3,701
Physician Assistant $3,701
Quinn Schulte, P.a, P.A
Physician Assistant — Payments: $3,624
Physician Assistant $3,624
Mrs. Wendy Johnson, P.a.-C, P.A.-C
Physician Assistant — Payments: $3,592
Physician Assistant $3,592